Learn about the latest developments in lung cancer and hematologic malignancies.
All educational content is sponsored by BeOne Medicines.
Difficult conversations in hematology: Presenting treatment options for indolent lymphomas
6 May 2024
Difficult conversations in hematology: Discussing clinical trial enrolment with a patient
6 May 2024
A new era for BTK inhibitors in the management of B-cell lymphomas
1 May 2024
ASH 2023 updates: Acquired mutations on BTK inhibitor-containing therapies
29 Jan 2024
ASH 2023 updates: Switching BTK inhibitor monotherapy
29 Jan 2024
ASH 2023 updates: ALPINE study of zanubrutinib vs. ibrutinib in R/R CLL
29 Jan 2024
ASH 2023 updates: RT1 study of tislelizumab plus zanubrutinib in Richter transformation
29 Jan 2024
Managing toxicity with BTK inhibitors in Waldenström’s macroglobulinemia
19 Jul 2023
The role of BTK inhibitors and genetic testing in Waldenström’s macroglobulinemia
19 Jul 2023
ASH 2023 updates: BTK inhibitor monotherapy for treatment-naive CLL
Explore educational content in blood cancers, delivered by global experts. Browse previous webinar recordings...
Access on-demand discussions led by international experts and learn more about relevant topics in hematology.
Enhance your understanding of patient care with our interactive case studies on the diagnosis and treatment of...
Stay up-to-date with recent developments and best-practice in your field with these bite-sized updates from...
Meet the team of international experts behind all BeGenius content and activities.
